Clinical Significance of the Bacille Calmette-Guérin Site Reaction in Kawasaki Disease Patients Aged Less than 18 Months
- Author:
Sung Hyeon PARK
1
;
Jeong Jin YU
;
Jihye YOU
;
Mi Jin KIM
;
Eun Jung SHIN
;
Hyun Ok JUN
;
Jae Suk BAEK
;
Young Hwue KIM
;
Jae Kon KO
Author Information
- Publication Type:Original Article
- Keywords: Kawasaki disease; BCG vaccine; Children; Erythema
- MeSH: Aneurysm; BCG Vaccine; Child; Chungcheongnam-do; Conjunctivitis; Coronary Vessels; Diagnosis; Erythema; Exanthema; Extremities; Humans; Incidence; Logistic Models; Lymphatic Diseases; Mucocutaneous Lymph Node Syndrome; Mucous Membrane; Mycobacterium bovis; Vaccination
- From:Pediatric Infection & Vaccine 2018;25(3):148-155
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: The purpose of this study was to investigate the clinical significance of Bacille Calmette-Guérin (BCG) site reaction in terms of diagnosis and outcome prediction in young children with Kawasaki disease (KD). METHODS: The incidence of BCG site reaction in the respective age ranges was investigated in 1,058 patients who were admitted at Asan Medical Center between January 2006 and February 2017. The 416 patients under 18 months of age were enrolled as subjects for the analysis of the association between BCG site reaction and other laboratory and clinical findings. The analysis was performed separately in complete and incomplete KD groups. RESULTS: The incidence rate of BCG site reaction was peaked at 6–12 months (83%) and decreased with increasing age after 12 months in 1,058 patients (P < 0.001). The incidence rate was above 70% in KD aged less than 18 months and more frequent than those of cervical lymphadenopathy. The logistic regression analyses showed that the principal clinical findings including conjunctivitis (P=0.781), red lips/oral mucosa (P=0.963), rash (P=0.510), cervical lymphadenopathy (P=0.363), changes in extremities (P=0.283) and the coronary artery aneurysm (P=0.776) were not associated with the BCG site reaction. CONCLUSIONS: The BCG site reaction could be a useful diagnostic tool independent to principal clinical findings in KD developing in children aged < 18 months, who underwent BCG vaccination. Outcome of KD patients was not different between groups with or without the BCG site reaction in both complete KD and incomplete KD.
